Leonardo Ramos Ferreira, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address513 Parnassus Ave
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard UniversityPh.D.2016Biochemistry
    Collapse Awards and Honors
    American Association of Immunologists (AAI)2018AAI Trainee Poster Award
    University of California San Francisco (UCSF) Postdoc Slam 20172017Finalist
    Federation of Clinical Immunology Societies (FOCIS) Center of Excellence2017Best Poster Award
    Federation of Clinical Immunology Societies (FOCIS) Center of Excellence2017Travel Award
    American Association of Immunologists (AAI)2015Travel Award

    Collapse Overview 
    Collapse Overview
    Cell-based gene therapies offer unprecedented promise for medicine. One day, it may be possible to cure degenerative diseases consisting of the loss of specialized cellular functions. However, several hurdles must be surpassed to establish cell transplantation therapies. A major one is rejection by the recipient's immune system. This challenge is particularly prominent for autoimmune disorders, such as type 1 diabetes and multiple sclerosis, where the immune system mediates the destruction of self-tissues. Currently, I am a postdoctoral scholar in the Tang and Bluestone laboratories at the Department of Surgery and Diabetes Center at UCSF. I envision that we will be able to use our capacity to engineer the human genome to manipulate our immune system with high precision and efficiency, enabling us to treat devastating illnesses now labeled as incurable. I am highly committed to make this vision become a reality.

    Collapse Interests

    Collapse ORNG Applications 
    Collapse In The News
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Abreu PL, Cunha-Oliveira T, Ferreira LMR, Urbano AM. Hexavalent chromium, a lung carcinogen, confers resistance to thermal stress and interferes with heat shock protein expression in human bronchial epithelial cells. Biometals. 2018 Mar 16. PMID: 29549560.
      View in: PubMed
    2. Tilburgs T, Meissner TB, Ferreira LMR, Mulder A, Musunuru K, Ye J, Strominger JL. NLRP2 is a suppressor of NF-?B signaling and HLA-C expression in human trophoblasts†,‡. Biol Reprod. 2017 Apr 01; 96(4):831-842. PMID: 28340094.
      View in: PubMed
    3. Ferreira LMR, Meissner TB, Tilburgs T, Strominger JL. HLA-G: At the Interface of Maternal-Fetal Tolerance. Trends Immunol. 2017 04; 38(4):272-286. PMID: 28279591.
      View in: PubMed
    4. Ferreira LM, Tang Q. Generating Antigen-Specific Regulatory T Cells in the Fast Lane. Am J Transplant. 2017 Apr; 17(4):851-853. PMID: 28102024.
      View in: PubMed
    5. Ferreira LM, Meissner TB, Mikkelsen TS, Mallard W, O'Donnell CW, Tilburgs T, Gomes HA, Camahort R, Sherwood RI, Gifford DK, Rinn JL, Cowan CA, Strominger JL. A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface. Proc Natl Acad Sci U S A. 2016 May 10; 113(19):5364-9. PMID: 27078102; PMCID: PMC4868469 [Available on 11/10/16].
    6. Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, Vrbanac V, Garrison BS, Stortchevoi A, Bryder D, Musunuru K, Brand H, Tager AM, Allen TM, Talkowski ME, Rossi DJ, Cowan CA. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell. 2014 Nov 06; 15(5):643-52. PMID: 25517468; PMCID: PMC4269831.
    7. Abreu PL, Ferreira LM, Alpoim MC, Urbano AM. Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer. Biometals. 2014 Jun; 27(3):409-43. PMID: 24664226.
      View in: PubMed
    8. Meissner TB, Mandal PK, Ferreira LM, Rossi DJ, Cowan CA. Genome editing for human gene therapy. Methods Enzymol. 2014; 546:273-95. PMID: 25398345.
      View in: PubMed
    9. Ferreira LM. Gammadelta T cells: innately adaptive immune cells? Int Rev Immunol. 2013 Jun; 32(3):223-48. PMID: 23617235.
      View in: PubMed
    10. Ferreira LM, Mostajo-Radji MA. How induced pluripotent stem cells are redefining personalized medicine. Gene. 2013 May 10; 520(1):1-6. PMID: 23470844.
      View in: PubMed
    11. Mostajo-Radji MA, Ferreira LM.Changing cell identity to create true personalized medicine. Gac Med Bol. 2012; 35(2):76-79.
    12. Ferreira LM, Floriddia EM, Quadrato G, Di Giovanni S. Neural regeneration: lessons from regenerating and non-regenerating systems. Mol Neurobiol. 2012 Oct; 46(2):227-41. PMID: 22717989.
      View in: PubMed
    13. Urbano AM, Ferreira LM, Alpoim MC. Molecular and cellular mechanisms of hexavalent chromium-induced lung cancer: an updated perspective. Curr Drug Metab. 2012 Mar; 13(3):284-305. PMID: 22455553.
      View in: PubMed
    14. Ferreira LM, Hebrant A, Dumont JE. Metabolic reprogramming of the tumor. Oncogene. 2012 Sep 06; 31(36):3999-4011. PMID: 22231450.
      View in: PubMed
    15. Urbano AM, Ferreira LM, Cerveira JF, Rodrigues CF, Alpoim MC.DNA Repair and Human Health (ed. Sonya Vengrova). DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy. 2011; 177-238.
    16. Ferreira LM. Cancer metabolism: the Warburg effect today. Exp Mol Pathol. 2010 Dec; 89(3):372-80. PMID: 20804748.
      View in: PubMed
    Leonardo's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.